IL-1β 通过一种涉及LDLR和Rab27a的新途径诱导LDL转细胞
Erika Jang1,2, Tse Wing Winnie Ho1,2, John H Brumell3
1Keenan Centre for Biomedical Research, St. Michael's Hospital, Toronto, ON, Canada (E.J., T.W.W.H., C.W., W.L.L.).
Arteriosclerosis, thrombosis, and vascular biology
|July 11, 2024
概括
介质素-1β (IL-1β) 在早期动脉样硬化中通过一种涉及LDL受体 (LDLR) 和Rab27a的新途径促进低密度脂蛋白 (LDL) 转细胞. 这一发现可能解释了IL-1β如何加速早期心血管疾病.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 早期动脉样硬化涉及低密度脂蛋白 (LDL) 穿过内皮细胞的转细胞.
- 坎托斯试验显示,白蛋白-1β (IL-1β) 阻断在晚期动脉样硬化中减少了心血管事件.
- IL-1β在早期动脉样硬化和LDL转细胞的作用以前是未知的.
研究的目的:
- 为了研究IL-1β对LDL转细胞的作用,在早期动脉样硬化.
- 阐明IL-1β调节LDL运输的分子机制.
- 为了确定IL-1β介导的LDL转细胞化是否有助于早期心血管疾病.
主要方法:
- 使用全内部反射光显微镜在人类冠状动脉内皮细胞中量化LDL转细胞.
- 在小鼠体内研究涉及IL-1β和LDL注射以可视化大动脉门沉积.
- 对LDLR,Rab27a和Cav-1等关键分子进行基因操纵 (敲击,淘汰,过度表达).
主要成果:
- IL-1β诱导的LDL转细胞在皮科莫尔度,独立于已知的受体ALK-1和SR-BI.
- IL-1β增加了LDL受体 (LDLR) 表达,这对诱导的细胞转移至关重要.
- 敲除Rab27a或其效应物JFC1在体外和体内取消了IL-1β诱导的LDL转细胞化.
- 在LDLR或Rab27a缺乏的小鼠中,IL-1β诱导的LDL积累在小鼠大动脉中被阻止.
结论:
- IL-1β通过一种需要LDLR和Rab27a的新途径诱导LDL转细胞,这与基底转细胞形成不同.
- 这种由IL-1β驱动的途径可能在早期动脉样硬化的进展中发挥重要作用.
- 准这种途径可能为预防心血管事件提供新的治疗策略.
相关概念视频
Receptor-mediated Endocytosis
104.3K
Overview
104.3K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
The Early Endosome: Endocytosis of Transferrin
3.3K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.3K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K


